Licarin A is a candidate compound for the treatment of immediate hypersensitivity via inhibition of rat mast cell line RBL-2H3 cells

Takuya Matsui, Masataka Itoigawa|Journal of Pharmacy and Pharmacology|2015

Cited by 19